Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts.

International immunopharmacology - 5 Jan 2024

Long Jun-Yu, Li Rui-Zhe, Wang Dong-Xu, Liu Hui, Tian Jincheng, Ding Zi-Niu, Yan Lun-Jie, Dong Zhao-Ru, Hong Jian-Guo, Tian Bao-Wen, Han Cheng-Long, Zhao Hai-Tao, Li Tao

Abstract excerpt

BACKGROUND: The RET gene, which is frequently mutated across many types of cancer, has been proven to be critically involved in tumorigenesis and tumour development; however, its prediction of the therapeutic efficacy of immune checkpoint inhibitor (ICI) therapy remains to be elucidated. The present research aims to investigate the association between RET mutations and the efficiency of ICI therapy. METHOD: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Immune Checkpoint Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Lung Neoplasms

Share to Multivariate Analysis

Share to Mutation

Share to Proto-Oncogene Proteins c-ret

Source

Identifiers

PMID: 38061115
DOI: 10.1016/j.intimp.2023.111281

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive molecular analysis identifies RET alterations association with response of ICIs in multi-immunotherapy cohorts.PMID 38061115Read ↗

RET mutation as a putative prognostic biomarker for immune checkpoint inhibitors therapy in various malignanciesSemantic proximity Read ↗

Mutation of rearranged during transfection (RET) is associated with enhanced tumor immunogenicity and favorable outcomes in pan-cancer immunotherapy.Semantic proximity Read ↗

BRAF mutation predicts survival after immunotherapy across multiple cancer types.Semantic proximity Read ↗

RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer.Semantic proximity Read ↗

RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesSemantic proximity Read ↗

mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers.Semantic proximity Read ↗

RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma.Semantic proximity Read ↗

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.Semantic proximity Read ↗

Targeting RET alterations in cancer: Recent progress and future directions.Semantic proximity Read ↗

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatmentSemantic proximity Read ↗

SMO mutation affects tumor immuno-microenvironment and predicts the effect of immune checkpoint inhibitor: from NSCLC to multiple-cancersSemantic proximity Read ↗

Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.